Evidence map›Paper›PMID 35118834›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Under-Oil Autonomously Regulated Oxygen Microenvironments: A Goldilocks Principle-Based Approach for Microscale Cell Culture.

Chao Li, Mouhita Humayun, Glenn M Walker, Keon Young Park, Bryce Connors, Jun Feng, Molly C Pellitteri Hahn, Cameron O Scarlett, Jiayi Li, Yanbo Feng and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chao LiCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.ORCID 0000-0002-1126-0655
Mouhita HumayunDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Glenn M WalkerDepartment of Biomedical Engineering, University of Mississippi University, Madison, MS, 38677, USA.
Keon Young ParkDepartment of Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.
Bryce ConnorsDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Jun FengDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Molly C Pellitteri HahnAnalytical Instrumentation Center-Mass Spec Facility, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Cameron O ScarlettAnalytical Instrumentation Center-Mass Spec Facility, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jiayi LiDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Yanbo FengDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Ryan L ClarkDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Hunter HeftiDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jonathan SchropeSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53726, USA.
Ophelia S VenturelliDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
David J BeebeCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
Biotechnology Training ProgramT32GM135066 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SCOTT M. COYLE, BRIAN G FOX · 2020 to 2026
$7.0M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Under-oil open microfluidic system (UOMS) for studying systemic fungal infectionR01AI154940 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, MCCLEAN, MEGAN N · 2021 to 2025
$3.8M
An automated high-throughput tissue model for screening metastatic effectorsR01CA186134 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2015 to 2019
$3.1M
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase MicrofluidicsR01CA247479 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, LANG, JOSHUA MICHAEL · 2020 to 2024
$3.1M
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer PrognosisR01CA185251 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BASU, HIRAK S., BEEBE, DAVID J · 2014 to 2017
$2.9M
Elucidating the molecular and ecological design principles of stability and assembly of the human gut microbiotaR35GM124774 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Ophelia Venturelli · 2017 to 2026
$2.9M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell AnalysisR01CA181648 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BERRY, SCOTT M, LANG, JOSHUA MICHAEL · 2014 to 2018
$1.6M
Automated Tissue MicroarrayerS10OD023526 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MATKOWSKYJ, KRISTINA A. · 2018 to 2018
$184k
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA181648NCI NIH HHS R01 CA185251NCI NIH HHS R01 CA186134NCI NIH HHS R01 CA247479NHGRI NIH HHS T32 HG002760NIAID NIH HHS R01 AI154940NIBIB NIH HHS R01 EB010039NIGMS NIH HHS R35 GM124774NIGMS NIH HHS T32 GM135066NIGMS NIH HHS T32 GM140935NIH HHS S10 OD023526
6 · The paper itself

Abstract

Oxygen levels in vivo are autonomously regulated by a supply-demand balance, which can be altered in disease states. However, the oxygen levels of in vitro cell culture systems, particularly microscale cell culture, are typically dominated by either supply or demand. Further, the oxygen microenvironment in these systems is rarely monitored or reported. Here, a method to establish and dynamically monitor autonomously regulated oxygen microenvironments (AROM) using an oil overlay in an open microscale cell culture system is presented. Using this method, the oxygen microenvironment is dynamically regulated via the supply-demand balance of the system. Numerical simulation and experimental validation of oxygen transport within multi-liquid-phase, microscale culture systems involving a variety of cell types, including mammalian, fungal, and bacterial cells are presented. Finally, AROM is applied to establish a coculture between cells with disparate oxygen demands-primary intestinal epithelial cells (oxygen consuming) and Bacteroides uniformis (an anaerobic species prevalent in the human gut).

Indexed as

Cell Culture TechniquesOxygenAnimalsCoculture TechniquesEpithelial CellsHumansMammalsOxygenhomeostasismicroscale cell cultureoxygen microenvironmentphysioxiasupply-demand balance

Identifiers

PMID35118834
PMCPMC8981459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.